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Introduction: the dementia epidemic
Dementia is a group of brain 
disorders characterised by significant 
neurodegeneration leading to progressive loss 
of cognitive function. It is the most common 
neurological disorder in old age contributing 
to 11.9 years lived with disability in 
individuals aged 60 years and over.1 
Alzheimer’s disease (AD) is the most common 
form of dementia accounting for 60-70% 
of the cases. Other forms include vascular 
dementia (VaD), Lewy-body dementia (LBD), 
fronto-temporal dementia (FTD) and dementia 
secondary to disease.
Age remains the most important 
non-modifiable risk factor in developing 
dementia. Although it is possible to develop 
dementia early on in life, the risk increases 
exponentially with age. Women are most 
likely to develop AD and having a first 
degree relative with the condition increases 
the risk slightly compared to absent family 
history. Cardiovascular morbidities such as 
high blood pressure, hypercholesterolaemia, 
diabetes and obesity are major risk factors, 
as is stroke. Conversely, active engagement 
in mental, physical and social activities may 
delay the onset of the most common forms 
of dementia.
Symptoms are mainly characterised by a 
decline in recent memory, faulty judgment, 
confusion and loss of communication. 
With disease progression, memory decline 
worsens whereas language, attention, 
and executive functions become gradually 
impaired with patients losing the ability 
to perform activities of daily living such as 
dressing, washing and eating. At the end 
stage, dementia becomes so debilitating that 
the patients become mute, incontinent and 
unable to walk, with the consequence of 
becoming bedridden and prone to illness and 
infection.
Currently, there are 45 million people 
with dementia worldwide, with the majority 
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being women. This figure is projected to 
almost double every twenty years reaching 
76 million in 2030 and 136 million in 2050.2 
The global societal costs of dementia are 
enormous as the total estimated worldwide 
expenditure for the year 2010 was estimated 
to be €430 billion, equivalent to 1% of the 
world’s Gross Domestic Product.2 The latest 
prevalence estimates for Malta indicated 
that, in 2010, there were 5,198 individuals 
with dementia. This figure will reach 13,000 
in 2050, equivalent to 3.3% (1.16% males, 
2.14% females) of the total population.3 This 
will invariably put greater demands on the 
national health and social systems leading to 
significant socio-economic consequences as 
more people will reach out for public-funded 
services.
Dementia: gender differences
Age and gender are predominant risk 
factors in AD, the most common form of 
dementia. In general, women have greater 
life expectancies than man. Whether this 
contributes directly to a higher risk of 
developing AD is still debatable due to the 
uncertainty of what would have happened, in 
terms of neuropathology, if men survived to 
later ages.4
Research studies into the role of 
sex hormones and cognitive status have 
indicated that oestrogen may play an 
important role in dementia, particularly 
AD. Oestrogen has been reported to have 
beneficial effects on the brain, possibly 
acting as a protective factor in AD via its 
ability to promote the growth, survival 
and activity of cholinergic neurons.5,6,7 
However, the use of hormone replacement 
therapy (HRT) to protect cognitive decline 
in ageing has produced inconsistent results 
in observational studies. This may be partly 
due to the timing of commencing HRT, with 
the greatest protective effect in AD observed 
if therapy is initiated early in menopause.8 
Interestingly, such beneficial effects were 
only observed with the use of oestrogen as 
oestrogen-progesterone combination therapy 
was found to have detrimental effects on 
verbal memory.9,10
An emerging risk factor in dementia 
is depression. The greater the frequency 
and severity of depressive symptoms, the 
greater are the risks.11 On average, women 
have higher rates of depression than men. 
Depression is also linked to cardiovascular 
disease, the latter a significant risk factor for 
stroke.12 The manner with which depression 
affects the brain is still unclear. Post-mortem 
analysis of depressed patients has shown 
reduced hippocampal volume,13 a brain area 
important for memory formation. Animal 
models of depression reported reduced neural 
plasticity and a reduction in neurogenesis 
that was reversed on the administration 
of antidepressant drugs.14 Other important 
gender-related changes in AD and other 
related dementias such as Lewy-body 
dementia (LBD) include neuroinflammatory 
events. For example, the levels of hyaluronic 
acid, a molecule involved in the regulation 
of the inflammatory process, is higher in 
males with AD and LBD compared to female 
patients.15
The relationship between gender 
differences and AD pharmacotherapy has not 
yet been clearly established although animal 
studies have produced a substantial amount 
of evidence to support the hypothesis 
that sex may influence the response to 
acetylcholinesterase inhibitors (AChEIs), a 
class of drugs recommended to improve the 
cognitive symptoms in mild-to-moderate 
AD. In particular, testosterone may play an 
important role in producing the observed 
differences by its influence on the entry of 
AChEIs into the brain.16 Women are also more 
likely to respond to treatment with donepezil 
and rivastigmine, leading to less cognitive 
decline.17 In general, women with dementia 
are at a greater risk of being exposed to 
side-effects originating from drug-drug 
interactions as they are more subjected to 
polypharmacy compared to men.18
Caregiving: a woman’s world
Although the proportion of male caregivers 
is increasing, caregiving in dementia has 
traditionally been considered as an activity 
reserved for women. Caregiving, although 
rated as a positive experience for some, 
is normally associated with burden and 
psychological morbidity characterised 
by financial hardship, ill-health and 
social isolation.19 Although individuals 
with dementia require a high level of 
care, especially in the late stages of the 
condition, the majority of them live in 
the community. The largest proportion 
of caregivers is made up of spouses or 
children, mostly females.20 The motivations 
behind caregiving may be various and 
include a sense of duty, social pressure, 
greed, love, reciprocity, guilt and religious 
contentment.21 Dementia caregiving is 
also time-consuming with a quarter of 
caregivers spending more than 11 hours 
per week providing informal support 
such as assisting with activities of daily 
living.20 It is therefore not surprising that 
caregivers experience mental health issues 
such as anxiety, stress and depression.22 
Financial costs are high and add to the 
burden of care. On average, an individual 
with dementia costs €22,000 per year in 
European member countries, of which 56% 
are costs of informal care.23
A number of studies suggest that 
gender-specific differences exist in 
the provision of dementia caregiving. 
Women approach caregiving differently 
and experience more stress and use 
more services than men.24 On average, 
wives continue to provide care for longer 
and husbands with dementia receive 
significantly more hours of care than wives 
with dementia do from their husbands.25 
Males experience fewer burdens in 
taking care of their wives with dementia, 
irrespective of the disease progression, 
even though male caregivers have higher 
levels of comorbidities.26 The latter may 
be due to the fact that gender differences 
exist in the way caregiving roles and coping 
strategies are perceived.27
The organisation of dementia caregiving 
in Malta was recently evaluated by Innes 
and colleagues.28 In the absence of 
Key points
•	 Alzheimer’s disease, the most common form of dementia, is more likely to be present 
in women. Symptoms include loss of recent memory, impaired communication skills, 
confusion and inability to perform activities of daily living.
•	 Oestrogen-replacement therapy can act as a protective factor against dementia if 
started early on in menopause. Oestrogen-progesterone combination therapy has been 
found to have no effect on lowering the risk of cognitive decline.
•	 Women are more likely to experience the burden of dementia care. They are also at a 
greater risk of developing depression, the latter an important risk factor in dementia.
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formal community services, families have 
developed innovative rotating care patterns 
to accommodate individual family member’s 
social and working lives. As with other 
countries, women are expected to provide 
most of the hands-on delivery of care with 
men participating only in decision taking. To 
meet the demands of their family lives and 
sole caregivers of a parent with dementia, 
women often have to give up their work. 
Although creative solutions in providing care 
for a relative with dementia are often found, 
rotation of care contributes to a situation 
where dementia caregiving is marginalised 
and dislocated from community life.28
In conclusion, important gender 
differences exist across various aspects of 
dementia. More research is needed focusing 
on the biological differences between the 
two sexes that has an impact on dementia 
onset and progression. Furthermore, more 
data is necessary on the effect of caregiving 
on men and women in order to design and 
develop tailor-made services that enhances 
the quality of life of patients and caregivers 
alike. 
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